United States· US:46708-019_8c5c7ad8-a128-4243-bd03-0e7057295b3f
MEPROBAMATE
A meprobamate product containing meprobamate, registered in United States by Alembic Pharmaceuticals Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Meprobamate is registered in 3 of 19 countries.
Countries holding a registration under ATC N05BC01 (meprobamate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Meprobamate · ATC N05BC01
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MEPROBAMATE
- Manufacturer
- Alembic Pharmaceuticals Limited
- Country
- United States (US)
- ATC code
- N05BC01
- ATC class
- Meprobamate
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1146708-019-30
- ndc1146708-019-71
- ndc1146708-019-91
- ndc11467080193030 TABLET in 1 BOTTLE (46708-019-30)
- ndc114670801971100 TABLET in 1 BOTTLE (46708-019-71)
- ndc1146708019911000 TABLET in 1 BOTTLE (46708-019-91)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
90 interactions on record for meprobamate.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Meprobamate · interactions on record
90 records
- 4 severe
- 60 moderate
- 26 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Meprobamate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5a331654-9f2e-4f20-908e-a33c118e99ee GET /v1/drugs/5a331654-9f2e-4f20-908e-a33c118e99ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "MEPROBAMATE",
"productndc": "46708-019",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"strength_unit": "mg/1",
"application_number": "ANDA090122",
"marketing_category": "ANDA"
}See everything about meprobamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.